Eukaryotic expression systems: A comparison

被引:59
作者
Geisse, S
Gram, H
Kleuser, B
Kocher, HP
机构
[1] Sandoz Pharma Ltd., Preclin. Research/Biotechnology
关键词
D O I
10.1006/prep.1996.0101
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic expression systems are frequently employed for the production of recombinant proteins as therapeutics as well as research tools. Most commonly used expression systems are based on stably transfected adherent CHO cells or nonadherent lymphoid cell lines. An efficient alternative is the infection of insect cells by recombinant baculoviruses. Transient expression in mammalian cells, e.g., COS cells, is often used for the production of smaller quantities of proteins. The choice of a suitable expression system depends largely on the biochemical and biological properties of the protein of interest, as well as on the nature of the planned experiments and the amount of recombinant protein required. We summarize here the expression of the cytokine human Leukemia Inhibitory Factor (hu-LIF) in five of the most commonly used systems, namely in CHO, Sp2/0, MEL, COS, and insect cells, in conjunction with an outline of the principles and characteristics of each of these expression systems. In result, the stably transfected cell lines, CHO, Sp2/0, and MEL cells, gave rise to production of fully glycosylated hu-LIF at variable product titers; incompletely glycosylated, albeit biological active hu-LIF could be rapidly produced by transient expression in COS cells or by baculovirus-mediated infection of insect cells. (C) 1996 Academic Press, Inc.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 111 条
[1]  
ALI SA, 1996, IN PRESS BIOCH J
[2]   THE HUMAN BETA-GLOBIN GENE CONTAINS MULTIPLE REGULATORY REGIONS - IDENTIFICATION OF ONE PROMOTER AND 2 DOWNSTREAM ENHANCERS [J].
ANTONIOU, M ;
DEBOER, E ;
HABETS, G ;
GROSVELD, F .
EMBO JOURNAL, 1988, 7 (02) :377-384
[3]   MOLECULAR-CLONING OF A CD28 CDNA BY A HIGH-EFFICIENCY COS CELL EXPRESSION SYSTEM [J].
ARUFFO, A ;
SEED, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8573-8577
[4]   TRANSFORMATION OF BOWES MELANOMA-CELLS WITH SV40 T-ANTIGEN [J].
ASSELBERGS, FAM .
JOURNAL OF BIOTECHNOLOGY, 1992, 26 (2-3) :301-313
[5]   CHARACTERIZATION OF NUCLEAR-PORE PROTEIN P62 PRODUCED USING BACULOVIRUS [J].
BAILER, SM ;
BERLIN, WK ;
STARR, CM ;
HANOVER, JA .
PROTEIN EXPRESSION AND PURIFICATION, 1995, 6 (04) :546-554
[6]   HIGH-LEVEL EXPRESSION OF A RECOMBINANT ANTIBODY FROM MYELOMA CELLS USING A GLUTAMINE-SYNTHETASE GENE AS AN AMPLIFIABLE SELECTABLE MARKER [J].
BEBBINGTON, CR ;
RENNER, G ;
THOMSON, S ;
KING, D ;
ABRAMS, D ;
YARRANTON, GT .
BIO-TECHNOLOGY, 1992, 10 (02) :169-175
[7]  
BEBBINGTON CR, 1987, DNA CLONING PRACTICA, V3, P163
[8]  
BERG DT, 1993, BIOTECHNIQUES, V14, P972
[9]   MAMMALIAN-CELL CULTURE SYSTEMS FOR RECOMBINANT PROTEIN-PRODUCTION [J].
BIRCH, JR ;
FROUD, SJ .
BIOLOGICALS, 1994, 22 (02) :127-133
[10]  
BISHOP DHL, 1992, BACULOVIRUS RECOMBIN, P27